Innovate Biopharmaceuticals (INNT) Short Interest Ratio & Short Volume → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free INNT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media Innovate Biopharmaceuticals Short Interest DataCurrent Short Volume2,170,000 sharesPrevious Short Volume2,210,000 sharesChange Vs. Previous Month-1.81%Dollar Volume Sold Short$1.52 millionShort Interest Ratio / Days to Cover4.1Last Record DateApril 30, 2020Outstanding Shares41,325,000 sharesFloat Size28,440,000 sharesShort Percent of Float7.63%Today's Trading Volume253 sharesAverage Trading Volume525,982 sharesToday's Volume Vs. Average0% Short Selling Innovate Biopharmaceuticals ? Sign up to receive the latest short interest report for Innovate Biopharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINNT Short Interest Over TimeINNT Days to Cover Over TimeINNT Percentage of Float Shorted Over Time Ad Behind the MarketsCentral Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>> Innovate Biopharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20202,170,000 shares $1.52 million -1.8%7.6%4.1 $0.70 4/15/20202,170,000 shares $978,670.00 -1.8%7.6%4.1 $0.45 3/31/20202,210,000 shares $1.11 million -1.5%7.8%4.1 $0.50 3/13/20202,243,800 shares $942,396.00 +7.9%7.9%10.4 $0.42 2/28/20202,080,000 shares $1.16 million -4.2%7.3%2.8 $0.56 2/14/20202,170,000 shares $1.71 million +17.3%8.2%3 $0.79 1/31/20201,850,000 shares $1.39 million +10.1%8.1%2.5 $0.75 1/15/20201,680,000 shares $1.09 million -8.2%7.3%2.4 $0.65 12/31/20191,830,000 shares $1.02 million +8.9%8.0%4.2 $0.56 8/15/20191,586,100 shares $1.24 million +9.5%12.0%4.6 $0.78 INNT Short Interest - Frequently Asked Questions What is Innovate Biopharmaceuticals' current short interest? Short interest is the volume of Innovate Biopharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 2,170,000 shares of INNT short. 7.63% of Innovate Biopharmaceuticals' shares are currently sold short. Learn More on Innovate Biopharmaceuticals' current short interest. What is a good short interest ratio for Innovate Biopharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INNT shares currently have a short interest ratio of 4.0. Learn More on Innovate Biopharmaceuticals's short interest ratio. What is a good short interest percentage for Innovate Biopharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.63% of Innovate Biopharmaceuticals' floating shares are currently sold short. Is Innovate Biopharmaceuticals' short interest increasing or decreasing? Innovate Biopharmaceuticals saw a drop in short interest in April. As of April 30th, there was short interest totaling 2,170,000 shares, a drop of 1.8% from the previous total of 2,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Innovate Biopharmaceuticals' float size? Innovate Biopharmaceuticals currently has issued a total of 41,325,000 shares. Some of Innovate Biopharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Innovate Biopharmaceuticals currently has a public float of 28,440,000 shares. How does Innovate Biopharmaceuticals' short interest compare to its competitors? 7.63% of Innovate Biopharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Innovate Biopharmaceuticals: Bruush Oral Care Inc. (89.06%), Grifols, S.A. (3.19%), LAVA Therapeutics (2.28%), Mainz Biomed (2.77%), NLS Pharmaceutics Ltd. (0.15%), Pharvaris (0.15%), Procaps Group S.A. (0.03%), Qilian International Holding Group Limited (0.80%), Athersys, Inc. (12.51%), TransCode Therapeutics, Inc. (2.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AbbVie Inc. ($7.01 billion), Charter Communications, Inc. ($4.31 billion), Match Group, Inc. ($2.95 billion), The Charles Schwab Co. ($2.81 billion), Tesla, Inc. ($2.69 billion), Microchip Technology Incorporated ($2.59 billion), Wayfair Inc. ($2.19 billion), Snap Inc. ($1.99 billion), The Clorox Company ($1.97 billion), and International Flavors & Fragrances Inc. ($1.92 billion). View all of the most shorted stocks. What does it mean to sell short Innovate Biopharmaceuticals stock? Short selling INNT is an investing strategy that aims to generate trading profit from Innovate Biopharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Innovate Biopharmaceuticals? A short squeeze for Innovate Biopharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INNT, which in turn drives the price of the stock up even further. How often is Innovate Biopharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INNT, twice per month. The most recent reporting period available is April, 30 2020. More Short Interest Resources from MarketBeat Related Companies: BRSH Short Interest GRFS Short Interest LVTX Short Interest MYNZ Short Interest NLSP Short Interest PHVS Short Interest PROC Short Interest QLI Short Interest ATHX Short Interest RNAZ Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INNT) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyMost important medical advance in 100 yearsThe Oxford ClubBuy this small stock before coming AI Tidal WaveChaikin Analytics